These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 33827)
1. [Effects of decaspiride on cyclic AMP phosphodiesterases in the brain and lung of the rat]. Vigano V; Pesce E; Piacenza G Farmaco Prat; 1978 May; 33(5):208-16. PubMed ID: 33827 [No Abstract] [Full Text] [Related]
2. Effect of SCH 15280, a new bronchodilator, on cyclic 3',5'-nucleotide phosphodiesterase activity and cyclic 3',5'-adenosine monophosphate levels in guinea pig lung. Kreutner W; Sherwood JE Biochem Pharmacol; 1977 May; 26(10):951-4. PubMed ID: 193512 [No Abstract] [Full Text] [Related]
3. Spiroquinazolinones as novel, potent, and selective PDE7 inhibitors. Part 1. Lorthiois E; Bernardelli P; Vergne F; Oliveira C; Mafroud AK; Proust E; Heuze L; Moreau F; Idrissi M; Tertre A; Bertin B; Coupe M; Wrigglesworth R; Descours A; Soulard P; Berna P Bioorg Med Chem Lett; 2004 Sep; 14(18):4623-6. PubMed ID: 15324876 [TBL] [Abstract][Full Text] [Related]
4. Rat brain and lung cyclic nucleotide phosphodiesterases: different responses to cromoglycate [proceedings]. Saeed SA; Butt NM; Taylor WA Biochem Soc Trans; 1979 Oct; 7(5):1037-8. PubMed ID: 229020 [No Abstract] [Full Text] [Related]
5. Elevated cAMP-phosphodiesterase in atopic disease: cause or effect? Townley RG J Lab Clin Med; 1993 Jan; 121(1):15-7. PubMed ID: 8381147 [No Abstract] [Full Text] [Related]
6. Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitors. Martin-Chouly CA; Astier A; Jacob C; Pruniaux MP; Bertrand C; Lagente V Life Sci; 2004 Jul; 75(7):823-40. PubMed ID: 15183075 [TBL] [Abstract][Full Text] [Related]
7. 2',3'-cyclic neucleotide 3'-phosphodiesterase activity in developing rat brain. Singh R; Shankar R Indian J Physiol Pharmacol; 1998 Jan; 42(1):147-50. PubMed ID: 9513810 [No Abstract] [Full Text] [Related]
8. [Inhibitory action of newly synthesized 1,3-dimethylxanthine derivatives on the 3',5'-cyclic AMP phosphodiesterase activity of the homogenates of various tissues]. Staneva D; Bogoslovova T; Pankova A Eksp Med Morfol; 1980; 19(3):154-9. PubMed ID: 6252004 [TBL] [Abstract][Full Text] [Related]
9. Spiroquinazolinones as novel, potent, and selective PDE7 inhibitors. Part 2: Optimization of 5,8-disubstituted derivatives. Bernardelli P; Lorthiois E; Vergne F; Oliveira C; Mafroud AK; Proust E; Pham N; Ducrot P; Moreau F; Idrissi M; Tertre A; Bertin B; Coupe M; Chevalier E; Descours A; Berlioz-Seux F; Berna P; Li M Bioorg Med Chem Lett; 2004 Sep; 14(18):4627-31. PubMed ID: 15324877 [TBL] [Abstract][Full Text] [Related]
10. Effects of antiallergic agents, compound 48/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate phosphodiesterases. Bergstrand H; Kristoffersson J; Lundquist B; Schurmann A Mol Pharmacol; 1977 Jan; 13(1):38-43. PubMed ID: 189182 [No Abstract] [Full Text] [Related]
11. Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung. Fertel R; Weiss B Mol Pharmacol; 1976 Jul; 12(4):678-87. PubMed ID: 183099 [No Abstract] [Full Text] [Related]
12. [Effect of etimizol on rat brain adenyl cylase and 3',5'-adenosine monophosphate phosphodiesterase activity]. Migas EA; Bul'on VV Farmakol Toksikol; 1974; 37(6):710-1. PubMed ID: 4377131 [No Abstract] [Full Text] [Related]
13. Effect of lithium on cyclic 3',5'-adenosine monophosphate formation in brain slices and its influence on phosphodiesterase. Krulík R Arzneimittelforschung; 1977; 27(9):1660-3. PubMed ID: 200249 [TBL] [Abstract][Full Text] [Related]
14. Airway relaxant and anti-inflammatory properties of a PDE4 inhibitor with low affinity for the high-affinity rolipram binding site. Martin C; Göggel R; Dal Piaz V; Vergelli C; Giovannoni P; Ernst M; Uhlig S Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):284-9. PubMed ID: 11919652 [TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase inhibitors in airways disease. Fan Chung K Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289 [TBL] [Abstract][Full Text] [Related]
16. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases. Kuo JF; Shoji M; Brackett NL; Helfman DM J Cyclic Nucleotide Res; 1978 Dec; 4(6):463-74. PubMed ID: 85641 [TBL] [Abstract][Full Text] [Related]
17. Selective phosphodiesterase 4 inhibitors in the treatment of allergy and inflammation. Smith VB; Spina D Curr Opin Investig Drugs; 2005 Nov; 6(11):1136-41. PubMed ID: 16312135 [TBL] [Abstract][Full Text] [Related]
18. Studies on the effect of nicotinamide and ethylnicotinic acid on cyclic AMP phosphodiesterase from rat liver. Hoshi Y Bull Osaka Med Sch; 1975 Oct; 21(2):77-91. PubMed ID: 181108 [No Abstract] [Full Text] [Related]
19. [Effect of imidazole compounds on the activity of adenosine-3', 5'-monophosphoric acid phosphodiesterase]. Lunts VIa Biull Eksp Biol Med; 1976 Sep; 82(9):1055-9. PubMed ID: 186138 [TBL] [Abstract][Full Text] [Related]
20. [Effect of benzimidazole derivatives and levamisole (phenylimidothiazole) on cyclic 3':5'-AMP phosphodiesterase from pig brain]. Kochetkova MN; Ozeretskovskaia NN Biokhimiia; 1982 Jul; 47(7):1208-11. PubMed ID: 6288125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]